Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman has maintained an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) and raised the price target from $37 to $41.
October 11, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Keurig Dr Pepper and increased the price target from $37 to $41, indicating a positive outlook.
The increase in price target from $37 to $41 by Barclays suggests a positive outlook for Keurig Dr Pepper, likely leading to a short-term increase in stock price. The Overweight rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100